Shawn Ritchie | Chief Executive Officer
Med-Life Discoveries

Shawn Ritchie, Chief Executive Officer, Med-Life Discoveries

Dr. Ritchie is the CEO and Chief Scientific Officer for Med-Life Discoveries (MLD). Dr. Ritchie has a PhD in Biochemistry and more than 18 years’ experience in industrial metabolomics, biomarker discovery and validation, disease risk modelling, and therapeutically-focused metabolic replacement strategy. He is the inventor of several commercial mass spec-based metabolic screening tests, and is now responsible for the development of MLD’s first in-class synthetic plasmalogen replacement program for the treatment of RCDP, Alzheimer’s, and Parkinson’s disease

Appearances:



World Orphan Drug Congress USA 2019 - Day 1 @ 16:40

Pitch 17: Synthetic plasmalogen precursor PPI-1040 for the treatment of Rhizomelic Chondrodysplasia Punctata (RCDP) and other rare pediatric peroxisomal disorders

last published: 24/Mar/19 01:45 GMT

back to speakers